Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00628134 · ClinicalTrials.gov registry record · NA
Self-dispersing Liquids as Aerosol Drug Carriers
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00628134 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 8 participants.
The verdict
NCT00628134, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Inhaled medications are often used to treat lung diseases such as cystic fibrosis. We are performing this study to determine whether inhaled medications dissolved in surfactant-based solutions will distribute more evenly throughout the lungs when compared to standard saline-based solutions. We think that inhaling medication that is in a surfactant-based liquid will result in more medication reaching partially blocked parts of the lung. This study will use a special nuclear medicine test called an aerosol deposition scan to compare how a drug spreads in the lung using a surfactant-based aerosol compared to a saline-based aerosol.
Interventions
- DRUG calfactant
- DRUG isotonic saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00628134
The ClinicalTrials.gov registry entry for NCT00628134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which calfactant is the first listed.
NCT00628134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00628134 about?
NCT00628134 is a clinical study titled "Self-dispersing Liquids as Aerosol Drug Carriers". Inhaled medications are often used to treat lung diseases such as cystic fibrosis. We are performing this study to determine whether inhaled medications dissolved in surfactant-based solutions will distribute more evenly throughout the lungs when compared to standard saline-based solutions. We think...
What is the current status of trial NCT00628134?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2008-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00628134?
The interventions under investigation include: calfactant (DRUG), isotonic saline (DRUG).
Who is sponsoring clinical trial NCT00628134?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.